EUPRAXIA PHARMACEUTICALS
Eupraxia Pharmaceuticals, through research and development and collaboration of experts within the medical field (both individuals and enterprise), is discovering, developing, and plans to market innovative technologies for some of society’s most prevalent diseases. The company is advancing the development of a wide portfolio of potential drug and drug delivery system opportunities. Eupraxia intends to provide and continue to build value to its shareholders and to society through the developme... nt and marketing of its revolutionary drug and drug delivery platform combination developed in cooperation with its joint venture partner. By joining forces with a company that has a successful history of getting drugs to market Eupraxia is increasing value to shareholders by decreasing risk and making the trajectory of getting the drug to patients more linear and faster.
EUPRAXIA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2012-01-01
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.eupraxiapharma.com
Total Employee:
1+
Status:
Active
Contact:
604-558-0920
Email Addresses:
[email protected]
Total Funding:
21.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Google Maps Google Analytics 4
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Interactive Forums, Inc.
Interactive Forums, Inc. is Creating critical insights and engagement through meaningful collaboration with healthcare experts
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Eupraxia Pharmaceuticals
Official Site Inspections
http://www.eupraxiapharma.com Semrush global rank: 8.59 M Semrush visits lastest month: 284
- Host name: 20.42.128.96
- IP address: 20.42.128.96
- Location: United States
- Latitude: 47.6092
- Longitude: -122.3314
- Timezone: America/Los_Angeles
More informations about "Eupraxia Pharmaceuticals"
Eupraxia Pharmaceuticals Inc., Author at Life Sciences British …
Email [email protected]; Address 201-2067 Cadboro Bay Road Victoria, BC V8R 5G4; Leadership Contact James Helliwell CEO, Amanda Malone CSO, Bruce Cousins President …See details»
Eupraxia Pharmaceuticals Announces that it has Closed a Non
Oct 31, 2024 For further details about Eupraxia, please visit the Company's website at: www.eupraxiapharma.com. ... Organization Profile. Eupraxia Pharmaceuticals Inc. Also from …See details»
Eupraxia Pharmaceuticals - Overview, News & Similar companies ...
Eupraxia Pharmaceuticals contact info: Phone number: (250) 590-3968 Website: www.eupraxiapharma.com What does Eupraxia Pharmaceuticals do? Founded in 2011, based …See details»
Eupraxia Pharmaceuticals Inc - The Globe and Mail
Eupraxia Pharmaceuticals Inc 201 2067 Cadboro Bay Road Victoria BC V8R 5G4 CAN P: 250-590-3968 https://www.eupraxiapharma.comSee details»
Eupraxia Pharmaceuticals Company Description - Stock Analysis
Company profile for Eupraxia Pharmaceuticals Inc. (TSX:EPRX) with a description, list of executives, contact details and other key facts.See details»
Eupraxia Pharmaceuticals Inc. (EPRX) - Yahoo Finance Canada
See the company profile for Eupraxia Pharmaceuticals Inc. (EPRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Eupraxia Pharmaceuticals Inc. - About Us - Our Core Values
Our Core Values Focus on the patient. Our patient-centric approach targets the areas of greatest need – where we can help patients and their healthcare providers achieve the best outcomes.See details»
EPRX - EUPRAXIA PHARMACEUTICALS INC | Company Profile
Feb 25, 2025 eupraxiapharma.com (250) 590-3968. [email protected]. Business Description. Eupraxia is a clinical-stage biotechnology company focused on the development …See details»
Eupraxia Pharmaceuticals - Craft
Eupraxia Pharmaceuticals has 5 employees at their 1 location. See insights on Eupraxia Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
Eupraxia Pharmaceuticals Inc. - Investors
Global multi-billion dollar market for lead candidate in osteoarthritis. U.S. market for osteoarthritis valued at almost US$2 billion; Current global osteoarthritis treatments challenged by poor …See details»
Eupraxia Pharmaceuticals Inc. Announces Research and …
Nov 4, 2021 VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug …See details»
Eupraxia Pharmaceuticals Announces Voting Results from Annual …
Jun 2, 2025 For investor and media inquiries, please contact: Danielle Egan, Eupraxia Pharmaceuticals Inc. [email protected] or Kevin Gardner , on behalf …See details»
Eupraxia Pharmaceuticals Inc. Provides Corporate Update and
May 14, 2021 Entered into an agreement with contract research organization Nordic Biosciences Clinical Development A/S ("NBCD") to conduct Eupraxia's EP-104IAR Phase 2 clinical trial in …See details»
Eupraxia Pharmaceuticals Inc. - Eupraxia Pharmaceuticals Doses …
VICTORIA, BC, June 8, 2023 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative …See details»
Eupraxia Pharmaceuticals Inc. - Eupraxia Pharmaceuticals …
Jul 7, 2022 Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, …See details»
Eupraxia Pharmaceuticals Announces CFO Succession - Yahoo …
Feb 18, 2025 Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has appointed …See details»
Eupraxia Pharmaceuticals Inc. - Careers - Job Details
Identifies plans, directs & implements all aspects of the organization's human resources policies, objectives, and initiatives. Act as a trusted advisor to the executive team on organizational …See details»
Eupraxia Pharmaceuticals Inc. - Career Application
Eupraxia Pharmaceuticals is an equal opportunity employer and considers qualified applicants for employment without regard to race, colour, creed, religion, national origin, sex, sexual …See details»
Eupraxia Pharmaceuticals Inc. - Our Science - Our Pipeline
Delivering Precision Therapy. Lead product candidate for treatment of osteoarthritis and eosinophilic esophagitis symptoms is a widely used corticosteroid with well-established …See details»